Gender disparities in optimal lipid control among patients with coronary artery disease. 2014

Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
Cardiovascular Division, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College.

Coronary heart disease(CHD) is the leading cause of death worldwide in both men and women. Hypercholesterolemia is a major factor contributing to the incidence of CHD. Many lipid-lowering trials have shown statins to be effective medications for the primary and secondary prevention of CHD. Some studies have suggested that statins are as or more effective in women than in men. However, there is a substantial gender gap in lipid goal attainment with respect to primary care guidelines, as reported in observational studies. In this article, we attempt to explain gender differences in lipid control in individuals with or at risk of CHD in order to improve awareness of and narrow gaps in gender disparities in lipid management.

UI MeSH Term Description Entries
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
May 2014, The American journal of cardiology,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
March 2011, The American journal of cardiology,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
January 2015, Journal of clinical lipidology,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
January 2014, International cardiovascular research journal,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
September 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
October 2016, Revista espanola de cardiologia (English ed.),
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
February 1998, Pacing and clinical electrophysiology : PACE,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
September 2002, Saudi medical journal,
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
October 2016, Revista espanola de cardiologia (English ed.),
Chun-Yen Chen, and Shao-Yuan Chuang, and Ching-Chang Fang, and Lien-Chi Huang, and I-Chang Hsieh, and Wen-Harn Pan, and Hung-I Yeh, and Chau-Chung Wu, and Wei-Hsien Yin, and Jaw-Wen Chen
January 2011, Women's health issues : official publication of the Jacobs Institute of Women's Health,
Copied contents to your clipboard!